Clorox finds vitamin business is a tough pill to swallow

Clorox finds vitamin business is a tough pill to swallow

bizjournals

Published

Clorox said Friday that it wrote down the value of its less-than-stellar vitamin, mineral and supplement business, taking an after-tax charge against earnings of $267 million.  That figure represents about 27% of acquiring the businesses, which was done across two deals, a $290 million acquisition of Renew Life Holdings Corporation in 2016 and a $700 million purchase of Nutranext in 2018. “There continue to be strong tailwinds in the VMS space,” the company told investors on the earning call.…

Full Article